DE60216776D1 - Neue piperidin-2,6-dion bisulfatsalze und deren verwendung für die behandlung stressbezogener gemütserkrankungen - Google Patents
Neue piperidin-2,6-dion bisulfatsalze und deren verwendung für die behandlung stressbezogener gemütserkrankungenInfo
- Publication number
- DE60216776D1 DE60216776D1 DE60216776T DE60216776T DE60216776D1 DE 60216776 D1 DE60216776 D1 DE 60216776D1 DE 60216776 T DE60216776 T DE 60216776T DE 60216776 T DE60216776 T DE 60216776T DE 60216776 D1 DE60216776 D1 DE 60216776D1
- Authority
- DE
- Germany
- Prior art keywords
- stress
- treatment
- bisulphate
- dion
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0120821 | 2001-08-28 | ||
GB0120821A GB2379216A (en) | 2001-08-28 | 2001-08-28 | Piperidin-2,6-dione salts useful for the treatment of stress-related affective disorders |
PCT/GB2002/003869 WO2003020275A1 (en) | 2001-08-28 | 2002-08-22 | Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60216776D1 true DE60216776D1 (de) | 2007-01-25 |
DE60216776T2 DE60216776T2 (de) | 2007-10-04 |
Family
ID=9921084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60216776T Expired - Lifetime DE60216776T2 (de) | 2001-08-28 | 2002-08-22 | Neue piperidin-2,6-dion bisulfatsalze und deren verwendung für die behandlung stressbezogener gemütserkrankungen |
Country Status (19)
Country | Link |
---|---|
US (1) | US7189742B2 (de) |
EP (1) | EP1420788B1 (de) |
JP (1) | JP2005502677A (de) |
KR (1) | KR100906893B1 (de) |
CN (1) | CN100506229C (de) |
AT (1) | ATE347891T1 (de) |
AU (1) | AU2002321522B2 (de) |
BR (1) | BR0212175A (de) |
CA (1) | CA2459009C (de) |
CY (1) | CY1105979T1 (de) |
DE (1) | DE60216776T2 (de) |
DK (1) | DK1420788T3 (de) |
ES (1) | ES2275898T3 (de) |
GB (1) | GB2379216A (de) |
IL (2) | IL160615A0 (de) |
MX (1) | MXPA04001777A (de) |
NZ (1) | NZ531345A (de) |
PT (1) | PT1420788E (de) |
WO (1) | WO2003020275A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0219639D0 (en) * | 2002-08-22 | 2002-10-02 | Prestwick Scient Capital Inc | Novel piperidin-2,6-dione salts and their use for the treatment of stress-related affective disorders |
US7560861B2 (en) | 2004-05-03 | 2009-07-14 | Lg Electronics Inc. | Organic electro-luminescence display device with an organic electro-luminescence array and fabricating method thereof |
KR100938296B1 (ko) * | 2005-03-15 | 2010-01-22 | 에프. 호프만-라 로슈 아게 | 5ht5a 수용체 길항제로서의2-아닐리노-3,4-다이하이드로-퀴나졸린의 용도 |
GB0518763D0 (en) * | 2005-09-14 | 2005-10-19 | Prestwick Pharmaceuticals Inc | Treatment of hypertension |
KR101401612B1 (ko) * | 2012-04-30 | 2014-06-02 | 재단법인 전남생물산업진흥원 | 석류 추출물을 유효성분으로 포함하는 스트레스성 질환의 치료 및 예방용 조성물 |
US20160051639A1 (en) * | 2014-08-25 | 2016-02-25 | Aimmune Therapeutics, Inc. | Egg protein formulations and methods of manufacture thereof |
WO2017087691A1 (en) | 2015-11-17 | 2017-05-26 | The Trustees Of Columbia University In The City Of New York | Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms |
WO2019094596A1 (en) | 2017-11-09 | 2019-05-16 | The Trustees Of Columbia University In The City Of New York | Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3693729A (en) * | 1970-02-19 | 1972-09-26 | Global Marine Inc | Air cushion drilling vehicle |
GB1455687A (en) * | 1972-12-28 | 1976-11-17 | Aspro Nicholas Ltd | Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines |
EP0216555B1 (de) * | 1985-09-11 | 1992-09-02 | Btg International Limited | Verwendung von Dioxopiperidin-Derivaten zur Behandlung von Anxietas, zur Herabsetzung von chronischen abnormal hohen Gehirn-Spiegeln Serotonins oder 5-Hydroxy-Indolessigsäure und zur Behandlung von bakteriellen oder viralen Infektionen |
EP0263594B1 (de) * | 1986-09-08 | 1992-06-24 | Btg International Limited | Dioxopiperidin-Derivate enthaltende anxiolytische Zusammensetzungen |
US5104990A (en) * | 1990-02-27 | 1992-04-14 | G. D. Searle & Co. | Process for the preparation of 3-aryl-3-aminoalkyl-2,6-dioxohexahydropyridines |
-
2001
- 2001-08-28 GB GB0120821A patent/GB2379216A/en not_active Withdrawn
-
2002
- 2002-08-22 PT PT02755226T patent/PT1420788E/pt unknown
- 2002-08-22 NZ NZ531345A patent/NZ531345A/en not_active IP Right Cessation
- 2002-08-22 AU AU2002321522A patent/AU2002321522B2/en not_active Ceased
- 2002-08-22 CA CA2459009A patent/CA2459009C/en not_active Expired - Fee Related
- 2002-08-22 MX MXPA04001777A patent/MXPA04001777A/es active IP Right Grant
- 2002-08-22 KR KR1020047002723A patent/KR100906893B1/ko not_active IP Right Cessation
- 2002-08-22 ES ES02755226T patent/ES2275898T3/es not_active Expired - Lifetime
- 2002-08-22 BR BR0212175-1A patent/BR0212175A/pt not_active IP Right Cessation
- 2002-08-22 WO PCT/GB2002/003869 patent/WO2003020275A1/en active IP Right Grant
- 2002-08-22 CN CNB028169123A patent/CN100506229C/zh not_active Expired - Fee Related
- 2002-08-22 EP EP02755226A patent/EP1420788B1/de not_active Expired - Lifetime
- 2002-08-22 DK DK02755226T patent/DK1420788T3/da active
- 2002-08-22 IL IL16061502A patent/IL160615A0/xx active IP Right Grant
- 2002-08-22 AT AT02755226T patent/ATE347891T1/de active
- 2002-08-22 JP JP2003524582A patent/JP2005502677A/ja active Pending
- 2002-08-22 US US10/486,925 patent/US7189742B2/en not_active Expired - Fee Related
- 2002-08-22 DE DE60216776T patent/DE60216776T2/de not_active Expired - Lifetime
-
2004
- 2004-02-26 IL IL160615A patent/IL160615A/en not_active IP Right Cessation
-
2007
- 2007-02-01 CY CY20071100144T patent/CY1105979T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE60216776T2 (de) | 2007-10-04 |
CA2459009C (en) | 2010-04-06 |
IL160615A0 (en) | 2004-07-25 |
IL160615A (en) | 2008-08-07 |
KR100906893B1 (ko) | 2009-07-08 |
JP2005502677A (ja) | 2005-01-27 |
MXPA04001777A (es) | 2004-11-22 |
DK1420788T3 (da) | 2007-02-26 |
GB0120821D0 (en) | 2001-10-17 |
US7189742B2 (en) | 2007-03-13 |
US20040249159A1 (en) | 2004-12-09 |
GB2379216A (en) | 2003-03-05 |
ATE347891T1 (de) | 2007-01-15 |
CN1549715A (zh) | 2004-11-24 |
EP1420788A1 (de) | 2004-05-26 |
ES2275898T3 (es) | 2007-06-16 |
CN100506229C (zh) | 2009-07-01 |
WO2003020275A1 (en) | 2003-03-13 |
BR0212175A (pt) | 2004-07-20 |
NZ531345A (en) | 2005-07-29 |
CA2459009A1 (en) | 2003-03-13 |
PT1420788E (pt) | 2007-03-30 |
EP1420788B1 (de) | 2006-12-13 |
AU2002321522B2 (en) | 2006-10-12 |
CY1105979T1 (el) | 2011-04-06 |
KR20040031000A (ko) | 2004-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0213778A (pt) | Composição, método de tratamento de um ser humano ou animal que sofre de doenças, e, uso da composição | |
HUP0302966A2 (hu) | Karboxamid-vegyületek és alkalmazásuk humán 11CBY receptor antagonistákként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
BR0206513A (pt) | Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos | |
DK1446387T3 (da) | Substituerede aryl, 1,4-pyrazinderivater | |
DE60238149D1 (de) | Arylsulfonamid-Derivate zur Verwendung als CCR3-Antagonisten bei der Behandlung von inflammatorischen und immunologischen Erkrankungen | |
CY1105979T1 (el) | Νεα οξινα θειικα αλατα πιπepιδινο-2,6-διονων και η χρηση τους για την αντιμετωπιση σχετιζομενων με το στρες συναισθηματικων διαταραχων | |
NO20071574L (no) | Arylsulfonylstilbenderivater for behandling av insomni og beslektede tilstander. | |
NO20051967L (no) | 3,4-disubstituerte pyroler og deres anvendelse ved behandling av inflammatoriske sykdommer. | |
ATE305451T1 (de) | 1-arenesulfonyl-2-aryl-pyrrolidin und piperidin derivative zur behandlung von cns-erkrankungen disorders | |
CY1105541T1 (el) | Παμοϊκα αλατα πιπεριδινο-2,6-διονων και η χρηση τους για την αντιμετωπιση σχετιζομενων με το στρες συναισθηματικων διαταραχων | |
NO20035116D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser | |
NO20035115D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser | |
BR0201569A (pt) | 4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7 | |
DE60117122D1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
NO20035117D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser | |
ATE287400T1 (de) | 4-(phenylpiperidin-4-ylidenmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen | |
ATE294780T1 (de) | Arylpiperidin- und aryl-1,2,5,6- tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität | |
NO941256L (no) | 3-(N-isopropyl-N-n-propylamino)-5-(N-isopropyl)karbamoylkroman | |
BR0206918A (pt) | Uso de iloperidona | |
NO20055514L (no) | Piperazinderivater og deres anvendelse ved behandling av neurologiske og psykiatriske sykdommer | |
ATE228126T1 (de) | 2- 4-(4-(4,5-dichlor-2-methylimidazol-1- yl)butyl)piperazin-1-yl -5-fluorpyrimidin, seine herstellung und therapeutische verwendung | |
DE602004019133D1 (de) | Verwendung von 1,2-diazadibenzoäe,hüazulenen zur herstellung von pharmazeutischen formulierungen für die behandlung und prävention von erkrankungen und störungen des zentralen nervensystems | |
NO20053612L (no) | 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet | |
SE0103647D0 (sv) | Therapeutic chromone compounds | |
TR200301671A2 (tr) | Sitalopram'ın yeni üretim formülasyonu. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |